Published in Vaccine Weekly, November 30th, 1998
The development was scheduled for publication in the November 25, 1998, issue of the Journal of the American Chemical Society.
Using vaccines to stimulate an immune response against cancer typically focuses on proteins, which are relatively easy to make but often are lodged within cells and not easily accessible to antibodies. Most of the good targets, or antigens,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly